Confirmation

EP3621614

LOTION COMPRISING TAZAROTENE FOR TOPICAL USE IN THE TREATMENT OF ACNE

  • :
    EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi
  • :
    11.5.2018
  • :
    25.6.2025
  • :
    18727965.8
  • :
    10.5.2038
  • :
    10.5.2026
  • :
    LOTION COMPRISING TAZAROTENE FOR TOPICAL USE IN THE TREATMENT OF ACNE

11.5.2018
25.6.2025
10.5.2026
  • :
    Bausch Health Ireland Limited
  • :
    3013 Lake Drive Citywest Business Campus, Dublin 24, IE
  • :
    ANGEL, Arturo
  • :
    Santa Rosa California 95409, US
  • :
    PILLAI, Radhakrishnan
  • :
    Santa Rosa, California 95409, US
  • :
    201762505421 P
  • :
    12.5.2017
  • :
    US
  • :
    US2018032359
  • :
    11.5.2018
  • :
    A61K 31/4436, A61K 9/00, A61K 47/14, A61K 47/32, A61K 9/107, A61P 17/10, A61K 9/06, A61K 47/44